[1]
Martell, K. et al. 2022. Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer. Canadian Urological Association Journal. 16, 8 (Mar. 2022), E437–42. DOI:https://doi.org/10.5489/cuaj.7752.